Latest
Paralign Health Raises $3M Seed to Expand EMS-Led Preventive Care InfrastructureParalign Health Raises $3M Seed to Expand EMS-Led Preventive Care Infrastructure|Blulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic PowerBlulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic Power|Secretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective AgainSecretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective Again|Trajectory Raises $15M Seed to Build Continual Learning AI InfrastructureTrajectory Raises $15M Seed to Build Continual Learning AI Infrastructure|Rightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic BattlegroundRightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic Battleground|Amusement Connect Raises Periscope Equity Investment for Cashless Arcade SoftwareAmusement Connect Raises Periscope Equity Investment for Cashless Arcade Software|Sychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive TrackingSychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive Tracking|Why Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup MarketWhy Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup Market|Salesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure TestSalesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure Test|AWS for Startups AI Visionaries Forum Signals the Next Enterprise AI BattlegroundAWS for Startups AI Visionaries Forum Signals the Next Enterprise AI Battleground|Paralign Health Raises $3M Seed to Expand EMS-Led Preventive Care InfrastructureParalign Health Raises $3M Seed to Expand EMS-Led Preventive Care Infrastructure|Blulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic PowerBlulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic Power|Secretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective AgainSecretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective Again|Trajectory Raises $15M Seed to Build Continual Learning AI InfrastructureTrajectory Raises $15M Seed to Build Continual Learning AI Infrastructure|Rightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic BattlegroundRightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic Battleground|Amusement Connect Raises Periscope Equity Investment for Cashless Arcade SoftwareAmusement Connect Raises Periscope Equity Investment for Cashless Arcade Software|Sychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive TrackingSychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive Tracking|Why Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup MarketWhy Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup Market|Salesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure TestSalesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure Test|AWS for Startups AI Visionaries Forum Signals the Next Enterprise AI BattlegroundAWS for Startups AI Visionaries Forum Signals the Next Enterprise AI Battleground
Back to articles

DOSS Raises $55M Series B to Replace Legacy ERP for Mid-Market Operators

Operational mess does not announce itself. It stacks quietly. Missed purchase orders. Inventory that looks right until it isn’t. Teams reconciling numbers that should have agreed hours ago. DOSS walked straight into that friction and decided it was solvable, not inevitable.

San Francisco just watched Wiley Jones and Arnav Mishra turn that conviction into $55M in Series B firepower, pushing total funding to $73M. Madrona and Premji Invest led the charge, with Intuit Ventures, Greyhound Capital, Commerce Ventures, Theory Ventures, General Catalyst, Contrary Capital, Mintaka VC, and Pathlight Ventures all pulling up a chair to the table. Not a casual dinner. More like a calculated bet that operations, long ignored and quietly cursed, is finally getting its moment

DOSS is not trying to charm you with theory. It is built for the operator who has outgrown duct tape systems but refuses to sign up for a 12-month ERP migraine. Procurement, inventory, orders, all moving in rhythm instead of stepping on each other’s toes. When Verve Coffee Roasters and Eight Sleep start seeing unfulfilled orders collapse and processing time shrink to near absurd levels, that is not marketing. That is what happens when friction gets audited and then eliminated with intent

Here is the part most people miss. This round is not just about capital. It is about timing. ERP has been the necessary evil for decades, expensive, slow, and just functional enough to survive. DOSS saw the gap between tools that break under growth and systems that break your budget, then built right in the middle of it. That is where markets open up, not with noise, but with precision.

Madrona and Premji Invest did not lean in because this sounds good on a slide. They leaned in because adoption is showing up where complexity lives. Mid market operators do not have time for philosophy. They pay for outcomes. DOSS is selling time back to teams who have been bleeding it quietly for years.

The lesson here is not just build better software. It is build where pain compounds. Wiley Jones and Arnav Mishra did not chase a trend. They followed a problem that refused to stay solved. That is how you earn a round like this without needing to shout about it. And if you are building in the physical world, moving atoms instead of just bits, you already know. Clean operations is not a luxury. It is survival with better margins and fewer headaches. DOSS just made that equation a lot harder to ignore.